RU2243764C2 - Применение производных пиридазино[4,5-b]индол-1-ацетамида для приготовления лекарств для лечения заболеваний, связанных с дисфункцией бензодиазепиновых рецепторов периферического типа - Google Patents

Применение производных пиридазино[4,5-b]индол-1-ацетамида для приготовления лекарств для лечения заболеваний, связанных с дисфункцией бензодиазепиновых рецепторов периферического типа Download PDF

Info

Publication number
RU2243764C2
RU2243764C2 RU2001121160/15A RU2001121160A RU2243764C2 RU 2243764 C2 RU2243764 C2 RU 2243764C2 RU 2001121160/15 A RU2001121160/15 A RU 2001121160/15A RU 2001121160 A RU2001121160 A RU 2001121160A RU 2243764 C2 RU2243764 C2 RU 2243764C2
Authority
RU
Russia
Prior art keywords
indole
pyridazino
compound
mmol
peripheral
Prior art date
Application number
RU2001121160/15A
Other languages
English (en)
Russian (ru)
Other versions
RU2001121160A (ru
Inventor
Бадь ФЕРЗАЗ (FR)
Бадья ФЕРЗАЗ
Хесус БЕНАВИДЕС (FR)
Хесус Бенавидес
Франк МАРГЭ (FR)
Франк МАРГЭ
Жак ФРУАССАН (FR)
Жак Фруассан
Бенуа МАРАБУ (FR)
Бенуа Марабу
Янник ЭВАННО (FR)
Янник Эванно
Миррей СЕВРЭН (FR)
Миррей СЕВРЭН
Филип ЖАНЬЯК (FR)
Филип ЖАНЬЯК
Original Assignee
Санофи-Синтелябо
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Санофи-Синтелябо filed Critical Санофи-Синтелябо
Publication of RU2001121160A publication Critical patent/RU2001121160A/ru
Application granted granted Critical
Publication of RU2243764C2 publication Critical patent/RU2243764C2/ru

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/535—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one oxygen as the ring hetero atoms, e.g. 1,2-oxazines
    • A61K31/5375—1,4-Oxazines, e.g. morpholine
    • A61K31/5377—1,4-Oxazines, e.g. morpholine not condensed and containing further heterocyclic rings, e.g. timolol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/50—Pyridazines; Hydrogenated pyridazines
    • A61K31/5025—Pyridazines; Hydrogenated pyridazines ortho- or peri-condensed with heterocyclic ring systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/12—Drugs for disorders of the urinary system of the kidneys
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P21/00—Drugs for disorders of the muscular or neuromuscular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Neurology (AREA)
  • Epidemiology (AREA)
  • Neurosurgery (AREA)
  • Biomedical Technology (AREA)
  • Urology & Nephrology (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Vascular Medicine (AREA)
  • Hospice & Palliative Care (AREA)
  • Psychiatry (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Dermatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
RU2001121160/15A 1999-01-26 2000-01-21 Применение производных пиридазино[4,5-b]индол-1-ацетамида для приготовления лекарств для лечения заболеваний, связанных с дисфункцией бензодиазепиновых рецепторов периферического типа RU2243764C2 (ru)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR9900806A FR2788696B1 (fr) 1999-01-26 1999-01-26 Utilisation de derives de pyridazino [4,5-b] indole-1-acetamide pour la preparation de medicaments destines aux maladies du systeme nerveux central
FR99/00,806 1999-01-26

Publications (2)

Publication Number Publication Date
RU2001121160A RU2001121160A (ru) 2003-05-20
RU2243764C2 true RU2243764C2 (ru) 2005-01-10

Family

ID=9541212

Family Applications (1)

Application Number Title Priority Date Filing Date
RU2001121160/15A RU2243764C2 (ru) 1999-01-26 2000-01-21 Применение производных пиридазино[4,5-b]индол-1-ацетамида для приготовления лекарств для лечения заболеваний, связанных с дисфункцией бензодиазепиновых рецепторов периферического типа

Country Status (32)

Country Link
US (1) US6395729B1 (https=)
EP (1) EP1148881B1 (https=)
JP (1) JP4688295B2 (https=)
KR (1) KR100694752B1 (https=)
CN (1) CN100577167C (https=)
AR (1) AR022413A1 (https=)
AT (1) ATE335487T1 (https=)
AU (1) AU764445B2 (https=)
BG (1) BG65152B1 (https=)
BR (1) BR0007718A (https=)
CA (1) CA2360754C (https=)
CO (1) CO5160242A1 (https=)
CY (1) CY1106257T1 (https=)
CZ (1) CZ294283B6 (https=)
DE (1) DE60029929T2 (https=)
DK (1) DK1148881T3 (https=)
EE (1) EE04905B1 (https=)
ES (1) ES2269097T3 (https=)
FR (1) FR2788696B1 (https=)
HK (1) HK1040905B (https=)
HU (1) HU228670B1 (https=)
IL (2) IL144181A0 (https=)
NO (1) NO321997B1 (https=)
NZ (1) NZ512981A (https=)
PL (1) PL193420B1 (https=)
PT (1) PT1148881E (https=)
RU (1) RU2243764C2 (https=)
SK (1) SK285707B6 (https=)
TR (1) TR200102134T2 (https=)
TW (1) TW541177B (https=)
UA (1) UA70349C2 (https=)
WO (1) WO2000044384A1 (https=)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
RU2512288C2 (ru) * 2008-10-02 2014-04-10 ДжиИ ХЕЛТКЕР ЛИМИТЕД Производные индола, подходящие для визуализации нейровоспаления

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1329493A (zh) * 1998-12-02 2002-01-02 辉瑞产品公司 恢复p53家族蛋白质的构象稳定性的方法和组合物
FR2811897A1 (fr) * 2000-07-24 2002-01-25 Sanofi Synthelabo UTILISATION DE DERIVES DE PYRIDAZINO[4,5-b]INDOLE-1- ACETAMIDE POUR LA PREPARATION DE MEDICAMENTS DESTINES AU TRAITEMENT DES DYSFONCTIONNEMENTS DES RECEPTEURS DE TYPE PERIPHERIQUE AUX BENZODIAZEPINES
FR2838124B1 (fr) 2002-04-03 2004-05-28 Sanofi Synthelabo Derives de 3-heteroaryl-3,5-dihydro-4-oxo-4h-pyridazino [4,5-b]indole-1-acetamide, leur preparation et leur application en therapeutique
FR2876715B1 (fr) 2004-10-19 2006-12-15 Profiles Du Ct Sa Embout de protection pour ecran de glissiere de securite routiere
GT200600005A (es) * 2005-01-12 2006-08-16 Un derivado de 2-(aminocarbonilo ciclico)-indolina y una composicion farmaceutica que lo contiene
CN101252914B (zh) * 2005-05-05 2013-03-27 塞诺菲-安万特美国有限责任公司 稳定的纳米粒制剂
BRPI0615259A2 (pt) * 2005-08-29 2011-05-17 Sanofi Aventis Us Llc forma cristalina de um derivado de piridazino[4,5-b] indol
CN101272767B (zh) * 2005-08-29 2012-08-29 赛诺菲-安万特美国有限责任公司 7-氯-N,N,5-三甲基-4-氧-3-苯基-3,5-二氢-4H-哒嗪并[4,5-b]吲哚-1-乙酰胺的无定形固体分散体
CN1946120B (zh) * 2006-10-20 2010-05-12 华为技术有限公司 实现话单关联的方法及系统
FR2918563B1 (fr) 2007-07-12 2009-12-04 Oreal Composition photoprotectrice fluide aqueuse a base d'un polymere polyamide a terminaison amide tertiaire.
FR2931064B1 (fr) 2008-05-14 2010-08-13 Oreal Composition cosmetique contenant un derive de dibenzoylmethane et un derive de pyrrolidinone; procede de photostabilisation du derive de dibenzoylmethane
CA2734448A1 (en) * 2008-08-18 2010-02-25 Sanofi-Aventis U.S. Llc Process for preparing polymorph of 7-chloro-n, n,5-trimethyl-4-oxo-3-phenyl-3,5-dihydr0-4h-pyridazin0[4,5-b]indole-1-acetamide
FR2936706B1 (fr) 2008-10-08 2010-12-17 Oreal Composition cosmetique contenant un derive de dibenzoylmethane et un compose dithiolane ; procede de photostabilisation du derive de dibenzoylmethane
EP2181717A1 (en) * 2008-10-28 2010-05-05 Sanofi-Aventis Use of 7-chloro-N,N,5-trimethyl-4-oxo-3-phenyl-3,5-dihydro-4H-pyridazino[4,5-B]indole-1-acetamide as a biomarker of peripheral benzodiazepine receptor levels
WO2011073279A2 (fr) 2009-12-18 2011-06-23 L'oreal Procédé de traitement cosmétique impliquant un composé apte à condenser in situ
FR2960773B1 (fr) 2010-06-03 2015-12-11 Oreal Procedes de traitement cosmetique utilisant un revetement a base d'un polymere polyamide-polyether
WO2019113248A1 (en) * 2017-12-07 2019-06-13 The Regents Of The University Of California Anti-upar antibody-drug conjugates and methods of use thereof

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB2290292A (en) * 1994-06-15 1995-12-20 Merck Sharp & Dohme 2-Phenylpyridazino[4,5-b]indole-1,4-dione derivatives as NMDA and AMPA antagonists
WO1998015552A1 (fr) * 1996-10-08 1998-04-16 Synthelabo DERIVES DE 1H-PYRIDO[3,4-b]INDOLE-4-CARBOXAMIDE, LEUR PREPARATION ET LEUR APPLICATION EN THERAPEUTIQUE

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3121137A1 (de) * 1981-05-27 1982-12-16 Hoechst Ag, 6000 Frankfurt Neue pyridazino(4,5-b)indole, verfahren zu ihrer herstellung, ihre verwendung sowie pharmazeutische praeparate auf basis dieser verbindungen, zwischenprodukte und deren herstellung"
US6069267A (en) * 1997-07-29 2000-05-30 E. I. Du Pont De Nemours And Company Selective synthesis of organodiphosphite compounds
FR2766823B1 (fr) * 1997-07-30 1999-10-08 Synthelabo Derives de 4-oxo-3,5-dihydro-4h-pyridazino[4,5-b] indole-1-acetamide, leur preparation et leur application en therapeutique
FR2788776B1 (fr) * 1999-01-26 2001-02-23 Synthelabo Derives de 4-oxo-3, 5-dihydro-4h-pyridazino [4,5-b] indole-1 -carboxamide, leur preparation et leur application en therapeutique

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB2290292A (en) * 1994-06-15 1995-12-20 Merck Sharp & Dohme 2-Phenylpyridazino[4,5-b]indole-1,4-dione derivatives as NMDA and AMPA antagonists
WO1998015552A1 (fr) * 1996-10-08 1998-04-16 Synthelabo DERIVES DE 1H-PYRIDO[3,4-b]INDOLE-4-CARBOXAMIDE, LEUR PREPARATION ET LEUR APPLICATION EN THERAPEUTIQUE

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
RU2512288C2 (ru) * 2008-10-02 2014-04-10 ДжиИ ХЕЛТКЕР ЛИМИТЕД Производные индола, подходящие для визуализации нейровоспаления

Also Published As

Publication number Publication date
UA70349C2 (en) 2004-10-15
FR2788696B1 (fr) 2004-03-05
WO2000044384A1 (fr) 2000-08-03
ATE335487T1 (de) 2006-09-15
CA2360754A1 (en) 2000-08-03
TW541177B (en) 2003-07-11
DE60029929D1 (de) 2006-09-21
CN1344161A (zh) 2002-04-10
CZ20012681A3 (cs) 2001-10-17
DE60029929T2 (de) 2007-08-30
HUP0201280A3 (en) 2004-12-28
CA2360754C (en) 2008-07-08
CN100577167C (zh) 2010-01-06
CY1106257T1 (el) 2011-06-08
PT1148881E (pt) 2006-12-29
KR20010089624A (ko) 2001-10-06
EE200100388A (et) 2002-12-16
KR100694752B1 (ko) 2007-03-14
NO321997B1 (no) 2006-07-31
PL349364A1 (en) 2002-07-15
AR022413A1 (es) 2002-09-04
DK1148881T3 (da) 2006-12-11
ES2269097T3 (es) 2007-04-01
NO20013645L (no) 2001-09-26
CO5160242A1 (es) 2002-05-30
EE04905B1 (et) 2007-10-15
SK10502001A3 (sk) 2002-01-07
BG105728A (en) 2002-02-28
PL193420B1 (pl) 2007-02-28
HUP0201280A2 (en) 2002-08-28
JP4688295B2 (ja) 2011-05-25
CZ294283B6 (cs) 2004-11-10
EP1148881A1 (fr) 2001-10-31
AU3057900A (en) 2000-08-18
TR200102134T2 (tr) 2003-03-21
HK1040905A1 (en) 2002-06-28
JP2002535370A (ja) 2002-10-22
HU228670B1 (en) 2013-05-28
IL144181A0 (en) 2002-05-23
NO20013645D0 (no) 2001-07-24
EP1148881B1 (fr) 2006-08-09
AU764445B2 (en) 2003-08-21
FR2788696A1 (fr) 2000-07-28
BG65152B1 (bg) 2007-04-30
US6395729B1 (en) 2002-05-28
NZ512981A (en) 2002-10-25
IL144181A (en) 2007-06-17
HK1040905B (zh) 2007-02-23
BR0007718A (pt) 2001-11-13
SK285707B6 (sk) 2007-06-07

Similar Documents

Publication Publication Date Title
RU2243764C2 (ru) Применение производных пиридазино[4,5-b]индол-1-ацетамида для приготовления лекарств для лечения заболеваний, связанных с дисфункцией бензодиазепиновых рецепторов периферического типа
EP1244670B1 (en) Hydantoin derivative compounds, pharmaceutical compositions, and methods of using same
EP0512817B1 (en) Pyridazinedione derivatives, their preparation and pharmaceutical applications
WO2002007727A1 (fr) Utilisation de derives de pyridazino (4, 5) indole-1-acetamide pour la preparation de medicaments destines au traitement des pathologies liees aux dysfonctionnements des recepteurs de type peripherique aux benzodiazepines
DE60216321T2 (de) 3-heteroaryl-3,5-dihydro-4-oxo-4h-pyridazinoä4,5-büindol-1-karboxamid-derivate, ihre herstellung und therapeutische verwendung
MXPA01007550A (en) USE OF PYRIDAZINO[4,5-b
US20020028814A1 (en) Aza compounds, pharmaceutical compositions and methods of use
WO2002008229A1 (fr) DERIVES DE 1-(4-OXO-3,5-DIHYDRO-4H-PYRIDAZINO [4,5-β] INDOLE-1-CARBONYL)PIPERAZINE, LEUR PREPARATION ET LEUR APPLICATION EN THERAPEUTIQUE
WO2001079177A1 (en) Cyclic diaza compounds for treating neurodegenerative disorders

Legal Events

Date Code Title Description
PD4A Correction of name of patent owner
MM4A The patent is invalid due to non-payment of fees

Effective date: 20140122